CoChat

Blockade of IL-17A/IL-17R Pathway Protected Mice from Sepsis-Associated Encephalopathy by Inhibition of Microglia Activation

Open access
Ye, Bo, Tao, Tianzhu, Zhao, Andong, Wen, Liyuan, He, Xiaofei, Liu, Yi, Fu, Qiang, Mi, Weidong, Lou, Jingsheng · 2019 · Mediators of Inflammation

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Abstract

Sepsis-associated encephalopathy (SAE) is a poorly understood condition that leads to long-term cognitive impairment and increased mortality in survivors. Recent research revealed that IL-17A/IL-17R might serve as a checkpoint in microglia-mediated neuroinflammation. The present study was designed to determine the specific role of IL-17A-mediated microglia activation in the development of SAE. A mouse model of SAE was induced by cecal ligation and puncture (CLP), and behavior performance was evaluated by the inhibitory avoidance test and the open field test. Cytokine expression and microglia activation in brain tissue were determined at 6 h, 12 h, 24 h, 48 h, and day 7 post surgery. Further, septic mice were intracerebral ventricle- (i.c.v.-) injected with recombinant IL-17A, anti-IL-17A ab, anti-IL-17R ab, or isotype controls to evaluate the potential effects of IL-17A/IL-17R blockade in the prevention of SAE. Septic peritonitis induced significant impairment of learning memory and exploratory activity, which was associated with a higher expression of IL-17A, IL-1 β , and TNF- α in the brain homogenate. Fluorescence intensity of Iba-1 and IL-17R in the hippocampus was significantly increased following CLP. Treatment with recombinant IL-17A enhanced the neuroinflammation and microglia activation in CLP mice. On the contrary, neutralizing anti-IL-17A or anti-IL-17R antibodies mitigated the CNS inflammation and microglia activation, thus alleviating the cognitive dysfunction. Furthermore, as compared to the sham control, microglia cultured from CLP mice produced significantly higher levels of cytokines and expressed with higher fluorescence intensity of Iba-1 in response to IL-17A or LPS. Pretreatment with anti-IL-17R ab suppressed the Iba-1 expression and cytokine production in microglia stimulated by IL-17A. In conclusion, blockade of the IL-17A/IL-17R pathway inhibited microglia activation and neuroinflammation, thereby partially reversing sepsis-induced cognitive impairment. The present study suggested that the IL-17A/IL-17R signaling pathway had an important, nonredundant role in the development of SAE.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2019/8461725

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 (a) Behavior performance was evaluated by the inhibitory avoidance test and the open field test at various time points following sham or CLP procedures. Each experiment was performed in triplicate and repeated at least twice (n = 5‐7 per group). (b) Cytokines of IL-17A, IL-1β, and TNF-α in brain homogenate were determined by ELISA. ∗P < 0.05vs. sham control, #P < 0.05 CLP day 7 vs. CLP 48 h, n = 5‐6 per group.
Figure 1 (a) Behavior performance was evaluated by the inhibitory avoidance test and the open field test at various time points following sham or CLP procedures. Each experiment was performed in triplicate and repeated at least twice (n = 5‐7 per group). (b) Cytokines of IL-17A, IL-1β, and TNF-α in brain homogenate were determined by ELISA. ∗P < 0.05vs. sham control, #P < 0.05 CLP day 7 vs. CLP 48 h, n = 5‐6 per group.CC BY · PubMed Central
Figure 2 Microglia activation in the hippocampus region was determined by IF at 6 h, 12 h, 24 h, 48 h, and day 7 post surgery. (a) Representative image of the IF assay in the hippocampus. Specimens were stained with CD11b (green), Iba-1 (red), and DAPI (blue). Representative images were merged and analyzed (1 : 200). Mean fluorescence intensity (MFI) of Iba-1 was shown in each image. (b) Summary data of CD11b and Iba-1 expression in the hippocampus region (n = 5‐6). ∗P < 0.05vs. sham control; #P < 0.05 CLP day 7 vs. CLP 48 h.
Figure 2 Microglia activation in the hippocampus region was determined by IF at 6 h, 12 h, 24 h, 48 h, and day 7 post surgery. (a) Representative image of the IF assay in the hippocampus. Specimens were stained with CD11b (green), Iba-1 (red), and DAPI (blue). Representative images were merged and analyzed (1 : 200). Mean fluorescence intensity (MFI) of Iba-1 was shown in each image. (b) Summary data of CD11b and Iba-1 expression in the hippocampus region (n = 5‐6). ∗P < 0.05vs. sham control; #P < 0.05 CLP day 7 vs. CLP 48 h.CC BY · PubMed Central
Figure 3 IL-17R expression in the hippocampus region was determined by IF at 6 h, 12 h, 24 h, 48 h, and day 7 post surgery. (a) Representative image of the IF assay in the hippocampus. Specimens were stained with IL-17R (green), Iba-1 (red), and DAPI (blue). Representative images were merged and analyzed (1 : 200). Mean fluorescence intensity (MFI) of IL-17R was shown in each image. (b) Summary data of IL-17R and Iba-1 expression in the hippocampus region (n = 5‐6). ∗P < 0.05vs. sham control; #P < 0.05 CLP day 7 vs. CLP 48 h.
Figure 3 IL-17R expression in the hippocampus region was determined by IF at 6 h, 12 h, 24 h, 48 h, and day 7 post surgery. (a) Representative image of the IF assay in the hippocampus. Specimens were stained with IL-17R (green), Iba-1 (red), and DAPI (blue). Representative images were merged and analyzed (1 : 200). Mean fluorescence intensity (MFI) of IL-17R was shown in each image. (b) Summary data of IL-17R and Iba-1 expression in the hippocampus region (n = 5‐6). ∗P < 0.05vs. sham control; #P < 0.05 CLP day 7 vs. CLP 48 h.CC BY · PubMed Central
Figure 4 Behavior performance and neuroinflammation were determined following the modulation of the IL-17A/IL-17R pathway. Mice received i.c.v. injection of recombinant IL-17A (20 ng), anti-IL17A ab (2 μg), anti-IL-17R ab (1 μg), isotype control (isotypeA: IgG1Ƙ 2 μg, isotypeB: IgG2A 1 μg), or saline. Samples were collected and analyzed at 12 h, 48 h, or 7 days post surgery. ∗P < 0.05vs. sham control; #P < 0.05 (CLP+anti-IL17A ab vs. CLP+isotypeA; CLP+anti-IL17R ab vs. CLP+isotypeB).
Figure 4 Behavior performance and neuroinflammation were determined following the modulation of the IL-17A/IL-17R pathway. Mice received i.c.v. injection of recombinant IL-17A (20 ng), anti-IL17A ab (2 μg), anti-IL-17R ab (1 μg), isotype control (isotypeA: IgG1Ƙ 2 μg, isotypeB: IgG2A 1 μg), or saline. Samples were collected and analyzed at 12 h, 48 h, or 7 days post surgery. ∗P < 0.05vs. sham control; #P < 0.05 (CLP+anti-IL17A ab vs. CLP+isotypeA; CLP+anti-IL17R ab vs. CLP+isotypeB).CC BY · PubMed Central
Figure 5 Microglia activation was determined by IF after modulation of the IL-17A/IL-17R pathway. (a) Representative image of the IF assay in the hippocampus at 12 hours post surgery (1 : 200). Specimens were stained with CD11b (green), Iba-1 (red), and DAPI (blue). Mean fluorescence intensity (MFI) of Iba-1 was shown in each image. (b) Summary data of the IF assay at 12 hours, 48 hours, and day 7 post CLP. ∗P < 0.05vs. sham control; #P < 0.05 (CLP+anti-IL17A ab vs. CLP+isotypeA; CLP+anti-IL17R ab vs. CLP+isotypeB).
Figure 5 Microglia activation was determined by IF after modulation of the IL-17A/IL-17R pathway. (a) Representative image of the IF assay in the hippocampus at 12 hours post surgery (1 : 200). Specimens were stained with CD11b (green), Iba-1 (red), and DAPI (blue). Mean fluorescence intensity (MFI) of Iba-1 was shown in each image. (b) Summary data of the IF assay at 12 hours, 48 hours, and day 7 post CLP. ∗P < 0.05vs. sham control; #P < 0.05 (CLP+anti-IL17A ab vs. CLP+isotypeA; CLP+anti-IL17R ab vs. CLP+isotypeB).CC BY · PubMed Central
Figure 6 (a) Primary microglial cells were collected and cultured with the purity of over 90%. Cells were stained with anti-CD11b antibody and examined by flow cytometry. (b) IL-17A or LPS induced cytokine production in microglia in vitro. Microglia cultured from CLP or sham-operated mice was pretreated with anti-IL-17R ab or isotype control and then stimulated with or without IL-17A (50 ng/ml or 100 ng/ml) or LPS (1 μg/ml). Supernatant was collected 24 h after stimulation and measured by ELISA. (c) Mean fluorescence intensity of Iba-1 in cultured microglia was determined by flow cytometry. ∗P < 0.05 vs. PBS control (sham group); #P < 0.05 vs. PBS control (CLP group); †P < 0.05 CLP vs. sham; $P < 0.05 vs. IL-17A 100 ng/ml (CLP group); ‡P < 0.05 vs. IL-17A 100 ng/ml (sham group).
Figure 6 (a) Primary microglial cells were collected and cultured with the purity of over 90%. Cells were stained with anti-CD11b antibody and examined by flow cytometry. (b) IL-17A or LPS induced cytokine production in microglia in vitro. Microglia cultured from CLP or sham-operated mice was pretreated with anti-IL-17R ab or isotype control and then stimulated with or without IL-17A (50 ng/ml or 100 ng/ml) or LPS (1 μg/ml). Supernatant was collected 24 h after stimulation and measured by ELISA. (c) Mean fluorescence intensity of Iba-1 in cultured microglia was determined by flow cytometry. ∗P < 0.05 vs. PBS control (sham group); #P < 0.05 vs. PBS control (CLP group); †P < 0.05 CLP vs. sham; $P < 0.05 vs. IL-17A 100 ng/ml (CLP group); ‡P < 0.05 vs. IL-17A 100 ng/ml (sham group).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 30 references

Cited by

See all 94

Metadata

Authors
Ye, B., Tao, T., Zhao, A., Wen, L., He, X., Liu, Y., Fu, Q., Mi, W., & Lou, J.
Affiliations
  • Chinese PLA General Hospital (CN)
  • Department of Anesthesiology, Air Force Medical Center, Beijing 100142, China
  • The First Laboratory of Air Force Medical Center, Beijing 100142, China
Corresponding author
  • Mi, Weidong
  • Lou, Jingsheng
Venue
Mediators of Inflammation
Publisher
Wiley
Published
2019-10-07
Volume
2019
Pages
1-11
ISSN
  • 0962-9351 (ISSN-L)
  • 1466-1861
OpenAlex
W2978958844
Cited by
83
References
30
Citations by year
2026: 7 · 2025: 13 · 2024: 19 · 2023: 11 · 2022: 16 · 2021: 11 · 2020: 6
FWCI
3.63
Type
journal article
Language
en
Open access
Locations
  • Mediators of Inflammation (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Natural Science Foundation of China (81501711)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
Keywords
microglial activation, neuroinflammation, cognitive impairment, cecal ligation and puncture, anti-IL-17A antibody, hippocampus, IL-1β, TNF-α, LPS
MeSH terms
Animals, Antibodies, Brain, Cells, Cultured, Disease Models, Animal, Fluorescent Antibody Technique, Male, Mice, Inbred C57BL, Signal Transduction, Microglia, Interleukin-17, Mice, Receptors, Interleukin-17, Cognitive Dysfunction, Sepsis-Associated Encephalopathy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Blockade of IL-17A/IL-17R Pathway Protected Mice from Sepsis-Associated Encephalopathy by Inhibition of Microglia Activation. https://app.cochat.ai/papers/10.1155/2019/8461725
The paper
Ye, B., Tao, T., Zhao, A., Wen, L., He, X., Liu, Y., Fu, Q., Mi, W., & Lou, J. (2019). Blockade of IL-17A/IL-17R Pathway Protected Mice from Sepsis-Associated Encephalopathy by Inhibition of Microglia Activation. Mediators of Inflammation. https://doi.org/10.1155/2019/8461725

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.